Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 236,830,423 papers from all fields of science
Search
Sign In
Create Free Account
bufuralol
Known as:
1-(7-ethylbenzofuran-2-yl)-2-tert-butylamino-1-hydroxyethane
, Bufuralolum
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (2)
Adrenergic beta-Antagonists
Ethanolamines
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1985
1985
Beta-adrenoceptor activity of the stereoisomers of the bufuralol alcohol and ketone metabolites.
P. Machin
,
D. Hurst
,
J. M. Osbond
Journal of Medicinal Chemistry
1985
Corpus ID: 38238645
The stereoisomers of 2-[(tert-butylamino)methyl]-7-methyl-2,7-benzofurandimethanol (2) and 2-[2-(tert-butylamino)-1-hydroxyethyl…
Expand
1984
1984
Acute Hemodynamic Effects of Bufuralol: A β-Adrenoceptor Blocking Drug with Vasodilatory Effects
M. Pfisterer
,
D. Burckhardt
,
F. Buhler
,
F. Burkart
Journal of Cardiovascular Pharmacology
1984
Corpus ID: 41765307
Simultaneous hemodynamic and equilibrium radionuclide function measurements were performed at rest and during exercise before and…
Expand
1984
1984
The effects of bufuralol, a beta-adrenoceptor antagonist with predominant beta 2-adrenoceptor agonistic activity, in the cat and the dog.
L. Blaber
,
D. Burden
,
R. Eigenmann
,
M. Gerold
Journal of Cardiovascular Pharmacology
1984
Corpus ID: 24555129
The effects of bufuralol and its carbinol metabolite have been compared with those of propranolol in the anaesthetised and…
Expand
1982
1982
Defective hydroxylation of bufuralol associated with side-effects of the drug in poor metabolisers.
P. Dayer
,
A. Kubli
,
A. Kupfer
,
F. Courvoisier
,
L. Balant
,
J. Fabre
British Journal of Clinical Pharmacology
1982
Corpus ID: 8185670
AHMAD R.A. & ROGERS H.J. (1980). Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographics…
Expand
1979
1979
Hemodynamic changes in hypertensive patients at rest and during physical exercise before and after acute i.v. administration of bufuralol-HCl or propranolol.
D. Magometschnigg
,
J. Bonelli
,
G. Kaik
,
H. Rameis
International journal of clinical pharmacology…
1979
Corpus ID: 39463492
The hemodynamic effects of 20 mg Bufuralol-HCl and of 15 mg Propranolol given to hypertensives i.v. at rest and under physical…
Expand
1978
1978
[Role of metabolites in the relationship between pharmacokinetics and the effect of beta blockers. Studies on tolamolol and bufuralol].
J. Tschopp
,
A. Gorgia
,
L. Balant
,
C. Revillard
,
R. Francis
,
F. Fabre
Swiss medical weekly
1978
Corpus ID: 38824490
Plasma concentrations of tolamolol and bufuralol (beta-blocking agents) were measured after oral and intravenous administration…
Expand
1978
1978
Decrease of peripheral resistance after acute intravenous application of a new beta-receptor blocking agents, bufuralol HCl.
D. Magometschnigg
,
J. Bonelli
,
G. Hitzenberger
,
G. Kaik
,
A. Korn
International journal of clinical pharmacology…
1978
Corpus ID: 46152628
The hemodynamic effects of a new beta-receptor blocking agent, bufuraolo HCl, were compared with those of pindolol. Contrary to…
Expand
1977
1977
Effect of β‐Blocking Agents and Angiotensin II on Isoproterenol‐Stimulated Renin Release from Rat Kidney Slices
A. Capponi
,
M. Gourjon
,
M. Vallotton
Circulation Research
1977
Corpus ID: 6850976
Mechanisms by which β-blocking agents decrease blood pressure and suppress renin release are incompletely understood. We…
Expand
1976
1976
Spectrofluorometric determination of bufuralol in blood and urine.
J. de Silva
,
J. Meyer
,
C. Puglisi
Journal of Pharmacy and Science
1976
Corpus ID: 22555682
The benzofuran analog bufuralol, a beta-adrenergic blocker, was determined in blood and urine by a specific and sensitive…
Expand
1976
1976
[Pharmacokinetics of two beta blocking drugs: detection of a pharmacogenetic abnormality].
L. Balant
,
A. Gorgia
,
J. Tschopp
,
C. Revillard
,
J. Fabre
Swiss medical weekly
1976
Corpus ID: 5827079
10 healthy male volunteers received orally either 100 mg tolamolol or 20 mg bufuralol. These experiments were repeated by…
Expand